Mini Lecture Series: Long-Acting, Injectable Cabotegravir-Rilpivirine (CAB-RPV)
25:34
Mini-Lecture Series: 2022 IAS-USA HIV Treatment and Prevention Guidelines
18:08
Mini-Lecture Series: HIV Entry Inhibitors: Mechanism of Action
19:09
Lenacapavir
17:21
Mini-Lecture Series: HIV Capsid Inhibitors: Mechanism of Action
19:25
Mini-Lecture Series: Guideline Update: HHS Adult & Adolescent Antiretroviral Treatment Guidelines
1:01:55
ICAP Grand Rounds — Long-Acting Injectable Cabotegravir for HIV Prevention: Promises and Pitfalls
22:52
Cabotegravir & Rilpivirine Long-acting Injections
18:33